QLS1510
/ Qilu Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 12, 2026
QLS1510-101: Phase I Study of QLS1510 Tablets in Healthy Participants
(clinicaltrials.gov)
- P1 | N=90 | Not yet recruiting | Sponsor: Shanghai Qilu Pharmaceutical Research and Development Center LTD
New P1 trial • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammation • Inflammatory Bowel Disease
1 to 1
Of
1
Go to page
1